COMMUNIQUÉS West-GlobeNewswire

Données Complètes à 12 Mois de l’Étude Pivot Américaine ACCCESS chez les Patients Atteints de Collapsus Concentrique Complet Présentées à l’ISSS 2026
15/10/2026
Données Complètes à 12 Mois de l’Étude Pivot Américaine ACCCESS chez les Patients Atteints de Collapsus Concentrique Complet Présentées à l’ISSS 2026 La stimulation bilatérale Genio® a permis une réduction médiane de 74 [...]
Syndax’s Revuforj® (revumenib) Named to TIME’s Best Inventions of 2026 List
15/10/2026
NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Revuforj ® (revumenib), the [...]
Opus Genetics Presents Positive Clinical Data from OPGx-BEST1 and OPGx-LCA5 Gene Therapy Programs at Retina in Rio 2026
15/10/2026
OPGx-BEST1 showed improved retinal sensitivity in 75% of evaluable participants in the initial low-dose Cohort 1 of the Company’s Phase 1/2 clinical trial, supporting further clinical development New BEST1 data analyses [...]
MDxHealth Announces Preliminary Third Quarter 2026 Revenue and Suspends Full-Year 2026 Revenue Guidance
15/10/2026
IRVINE, CA – October 15, 2026 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leader in urology-focused precision diagnostics, today announced preliminary unaudited revenue from [...]
Anavex Receives FDA Clearance of its IND Application for Blarcamesine in Fragile X Syndrome
15/10/2026
Anavex now has open INDs in all three core indications: Alzheimer's disease, Rett syndrome, and Fragile X syndrome Phase 2a study will evaluate the safety, tolerability and pharmacokinetics of blarcamesine oral solution [...]
Avance Clinical to Showcase its Early Phase Center of Excellence Model at AusBiotech International 2026
15/10/2026
Australian-headquartered global CRO with more than 30 years of early phase experience to meet sponsors at Stand #72, Gold Coast, 21–23 October 2026 ADELAIDE, Australia, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Avance Clinical [...]
Digbi Health Brings Precision Biology Care to All 50 States With 700+ Clinicians and Coaches Through OpenLoop Health and MD Integrations
15/10/2026
More than 300 employers and health plans now offer a unified platform for metabolic, inflammatory, and hormonal care, built on each member’s gut microbiome, genetics, and glucose data, as a fully covered benefit [...]
Booking Health Announces Medical Records Review, Specialist Second Opinions and Treatment Coordination for Pancreatic Cancer Patients Seeking Care in Germany
15/10/2026
Langenfeld, Germany --, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Booking Health, a medical travel coordination service, announces medical records review, specialist second opinions and full treatment coordination for [...]
Spineway : NINE-MONTH REVENUE
15/10/2026
Press release / Ecully, October 15, 2026 – 6 p.m. NINE-MONTH REVENUE: €8 MILLION Continued structuring to optimize supply and support the growth strategy Appointment of Erwan Martin as Deputy Chief Executive Officer In [...]
SPINEWAY : CHIFFRE D’AFFAIRES À 9 MOIS
15/10/2026
Communiqué de presse / Ecully, le 15 octobre 2026 – 18h CHIFFRE D’AFFAIRES 9 MOIS : 8 M€ Poursuite de la structuration pour optimiser les approvisionnements et contribuer à la stratégie de développement Nomination d’ [...]
VIP Plastic Surgery Designated an Accredited Medical Tourism Institution by South Korea’s Ministry of Justice
15/10/2026
Jeju clinic becomes one of two institutions on the island able to sponsor electronic medical visas for 2026-27 JEJU, South Korea, Oct. 15, 2026 (GLOBE NEWSWIRE) -- VIP Plastic Surgery , a Jeju clinic, has been [...]
Oxford Healthspan Launches Primeadine® GF Spermidine Powder, Expanding Its Gluten-Free Line
15/10/2026
New Mixable Gluten-Free Format Offers a More Flexible Way to Incorporate Spermidine Daily SHERIDAN, Wyo., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Oxford Healthspan today announced the launch of Primeadine® GF Spermidine [...]
Affidea signe un accord en vue d’acquérir deux centres Alliance Medical dans le centre de Londres, accélérant ainsi sa croissance au Royaume-Uni
15/10/2026
LONDRES, 15 oct. 2026 (GLOBE NEWSWIRE) -- Affidea , un prestataire paneuropéen de premier plan, spécialisé dans les cliniques de proximité, les examens diagnostiques de pointe et les services de santé privés spécialisés [...]
Neumarker and Cortica Enter Strategic Partnership to Advance Precision Autism Care
15/10/2026
Strategic Collaboration Focused on Precision Autism Care Partnership Brings Together Neumarker’s AI Platform and Cortica’s Clinical Expertise MOUNTAIN VIEW, Calif. and SAN DIEGO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- [...]
Chiesi Global Rare Diseases Supports Continued Generation of Real-World and Scientific Evidence in Epidermolysis Bullosa (EB), Including New Data Presented at 2026 PeDRA Annual Conference
15/10/2026
-- New mechanistic research and clinician-reported real-world experience adds to the evolving evidence base for birch triterpenes in EB -- -- Chiesi proudly marks EB Awareness Week (October 25–31) with continued [...]
Chiesi Global Rare Diseases Supports Continued Generation of Real-World and Scientific Evidence in Epidermolysis Bullosa (EB), Including New Data Presented at 2026 PeDRA Annual Conference
15/10/2026
-- New mechanistic research and clinician-reported real-world experience adds to the evolving evidence base for birch triterpenes in EB -- -- Chiesi proudly marks EB Awareness Week (October 25–31) with continued [...]
Canadians Overwhelmingly Support a Smoke-Free Generation Law, a New Poll Commissioned by National Lung Health Alliance Finds
15/10/2026
96% say preventing children from taking up smoking or vaping is important, while 76% support a Smoke-Free Generation, the same bold action the U.K. passed into law OTTAWA, Ontario, Oct. 15, 2026 (GLOBE NEWSWIRE) -- A [...]
Selon un nouveau sondage commandé par la National Lung Health Alliance, les Canadiennes et les Canadiens appuient en forte majorité une loi pour une génération sans fumée (aussi appelée « génération sans tabac »)
15/10/2026
96 % des personnes sondées estiment qu’il est important d’éviter que les enfants ne commencent à fumer ou à vapoter, tandis que 76 % appuient l’initiative pour une génération sans fumée, cette même mesure audacieuse que [...]
A Child's Light Partners with coeo Therapy to Expand Rapid-Response Youth Trauma Care into Montgomery County
15/10/2026
The Strategic Regional Expansion Bridges Crucial Mental Health Access Gaps, Connecting Traumatized Youth with Relational, Whole-Person Healing Within Days COLLEGEVILLE, PA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- A Child's [...]

Pages

Other news

Promaxo Announces Closing of Series C Financing and $100M Credit Facility

Contenu:

The growth capital will expand manufacturing capacity, reduce backlog, and support new regulatory filings

ProKidney to Host Virtual KOL Event to Recap Mechanism of Action Data Presented at ASN Kidney Week and Provide a Corporate Update

Contenu:

WINSTON-SALEM, N.C., Oct. 22, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp.

BreathiZen Introduces BreathiZen Spray - A New Multi-Ingredient Dietary Supplement For Your Respiratory Wellness

Contenu:

BreathiZen is a once-daily oral spray that brings together botanical extracts, an enzyme preparation, and selected nutrients in a 60 ml bottle designed to fit easily into an adult wellness routine.

New York, Oct. 22, 2026 (GLOBE NEWSWIRE) --

RenovoRx to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026

Contenu:

Company to host conference call on November 5, 2026, at 4:30 p.m. ET

BridgeBio to Report Third Quarter 2026 Financial Results and Commercial Updates on October 29, 2026 at 4:30 pm ET

Contenu:

PALO ALTO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc.

Ernexa Therapeutics Highlights ERNA-101’s Path Toward the Clinic and Differentiated Cell Therapy Platform in New “What This Means” Segment

Contenu:

Leadership discusses recent FDA engagement, the technology underlying ERNA-101 and the development strategy supporting planned first-in-human clinical evaluation

SciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome

Contenu:

TEL AVIV, Israel, Oct. 22, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that its subsidiary, NeuroThera Labs Inc.